Literature DB >> 2580615

Rapid and slow DNA rejoining in nondividing human diploid fibroblasts treated with bleomycin and ionizing radiation.

C W Moore, J B Little.   

Abstract

The rejoining of DNA single-strand breaks produced after bleomycin treatment or gamma-irradiation of human diploid fibroblasts was studied by the alkaline elution technique. DNA rejoining occurred at slower rates in bleomycin-treated human fibroblasts than in gamma-irradiated fibroblasts. These comparisons were made at similar levels of survival or DNA single-strand breaks (including alkali-labile lesions). Significant numbers of DNA single-strand breaks were detected routinely after 2 micrograms/ml (1.34 X 10(-6) M) bleomycin treatments (for 30 min, survival greater than 70%). Dose-dependent losses of approximately 3 to 15% of total radioactivity were measured in preelution samples from cells treated with bleomycin (2 to 100 micrograms/ml), but only 2 to 3.5% of total radioactivity was assayed in lysis samples from cells irradiated with 200 to 1000 rads. This result suggests that DNA was more degraded by or after bleomycin treatment. DNA was rejoined extremely rapidly after bleomycin or radiation treatments, and the rejoining was both agent- and dose-dependent. Over dose ranges yielding surviving fractions of 75 to 0.056%, considerable DNA rejoining occurred after only 2.5 min posttreatment incubation in conditioned medium. Cellular recovery occurred at faster rates after bleomycin treatments than after gamma-irradiation, while DNA rejoining occurred at faster rates after gamma-irradiation, thus uncoupling DNA repair and cellular recovery in relating the cellular action of these 2 agents. No consistent differences were observed among 3 normal fibroblast strains and fibroblasts from a Gardner's syndrome patient (deficient in their capacity for cellular recovery) or a Turcot's syndrome patient in the formation and rejoining of single-strand breaks after bleomycin or radiation treatments.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580615

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Biological heterogeneity and radiation sensitivity of in vitro propagated lung metastatic lines originated from a transplantable squamous cell carcinoma of BALB/c mouse.

Authors:  R J Jamasbi; E H Perkins
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

2.  Growth phase dependency of chromatin cleavage and degradation by bleomycin.

Authors:  C W Moore; C S Jones; L A Wall
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  DNA damage-inducible and RAD52-independent repair of DNA double-strand breaks in Saccharomyces cerevisiae.

Authors:  C W Moore; J McKoy; M Dardalhon; D Davermann; M Martinez; D Averbeck
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

4.  Lesions and preferential initial localization of [S-methyl-3H]bleomycin A2 on Saccharomyces cerevisiae cell walls and membranes.

Authors:  C W Moore; R Del Valle; J McKoy; A Pramanik; R E Gordon
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

5.  Effects of bleomycin on growth kinetics and survival of Saccharomyces cerevisiae: a model of repair pathways.

Authors:  D J Keszenman; V A Salvo; E Nunes
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

6.  Bleomycin-induced DNA repair by Saccharomyces cerevisiae ATP-dependent polydeoxyribonucleotide ligase.

Authors:  C W Moore
Journal:  J Bacteriol       Date:  1988-10       Impact factor: 3.490

7.  Protective effect of spin-labeled 1-ethyl-1-nitrosourea against oxidative stress in liver induced by antitumor drugs and radiation.

Authors:  V Gadjeva; B Grigorov; G Nikolova; A Tolekova; A Zheleva; M Vasileva
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

8.  Analysis of DNA fragmentation in human uterine cervix carcinoma HeLa S3 cells treated with duocarmycins or other antitumor agents by pulse field gel electrophoresis.

Authors:  A Okamoto; M Okabe; K Gomi
Journal:  Jpn J Cancer Res       Date:  1993-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.